Wholesale 99% High Quality GLP-2 Peptide Glepaglutide Raw Powder CAS 914009-86-2

• Customization: Available
• CAS No.: 914009-86-2
• Formula: /
• Model NO.: 914009-86-2
• EINECS: /
• Type: Lyophilized Powder
• Appearance: Powder
• Quality: Pharmaceutical Grade
• Colour: White
• Purity: ≥99.0%
• Arrivrd Time: 7-14days
• Delivery Time: 48h
• Storage Conditions: -20°c, Protect From Light, Dry, Sealed
• Transport Package: Vials/Tubes/Bottles
• Specification: 1g
• Trademark: ZB
• Origin: China
• Production Capacity: 100, 000 Vials Per Month

Product Description

Product Description

 

Glepaglutide is an long-acting GLP-2 analog that is stable in aqueous solution. We are developing glepaglutide as a ready-to-use, fixed dose product designed for subcutaneous delivery via auto-injector. 
 

We support samples, COA and support customization , if you have any questions, please feel free to communicate with me.

Pecifications

Peptide bottle labels	Size	custom
	Material	Peptide
	Use for	GLP-2
	Colors	white powder or liquid
	Design	customized
	MOQ	1 Box
	Types	1g
	Production time	7 business days after received deposit and approval of designs;
	Shipping	7-14 days
	payment	(payment by T/T, Bitcoin, Bank transfer ,Wise)
Quotation	negotiation	Base on information: How many product name types ? Quantity for each type? Send sample images to check which printing on products ;
More details	Quality	99% purity and Factory quality

 

QUOTATION AND ORDER PROCESS

HOW TO GET CHEAPER PRICE

1. More quantity, much cheap price;

2. Less design types, price is much cheaper owning to template cost;

3. simple colors is cheaper than different colors of each design;

4. If order whole set products, for example: vial labels+ box+hologram+glass vial+flip off cap

Rubber stopper+ Leaflets , the price is much cheaper than u order them seperatly;

 

 

 

 

Our Advantages: High purity, Wholesale price, large stock, Stealth Shipping, 100% Delivery Guarantee

Company

 

Zhaobo Bio acquired early mastery of development and manufacturing of peptides, the short chain amino acids linked by peptide bonds that have enabled new generations of small molecule drugs that closely mimic the body's natural pathways.
Now Zhaobo Bio possesses first-class capabilities to manufacture peptides at industrial scale and in full compliance with the strictest Good Manufacturing Practice (cGMP) standards.

Upstream peptide synthesis
Zhaobo Bio production plants are endowed with state-of-the-art equipment for solvent supply, peptide synthesis, purification and isolation of active ingredients and intermediates. All equipment and containment is GMP qualified and cleaning validated. Overlapping capacities and sizes of different equipment trains facilitate a smooth scale-up for increases in demand within the product life cycle. 

Downstream purification and isolation of peptides
Zhaobo Bio is committed to the systematic expansion and modernization of its purification equipment in order to ensure the efficient production of ever-increasing amounts of bulk peptide pharmaceuticals.
It uses sophisticated methods for large scale purification campaigns such as preparative high performance liquid chromatography (HPLC), ion exchange (IEX), size-exclusion chromatography (SEC), and ultra-filtration (UF/TFF). The equipment in place permits highly efficient or even continuous manufacturing of extremely pure products up to multi-kg quantities per lot.
For preparative HPLC, dynamic axial compression (DAC) stainless steel columns of up to 60 cm diameter both in batch and continuous mode are packed with the appropriate high performance silica separation phase. For low-pressure chromatography columns up to 80 cm diameter are available. Solvent delivery is ensured from eluent tank farms and containers.
The control of microbiological contamination is a prerequisite for API manufacturing. Class D (ISO 8) and C (ISO 7) clean rooms are supplied via HEPA-filtered, temperature and humidity controlled air, down-flow booths are used for minimizing microbial contamination and protecting operators. Highly active pharmaceutical ingredients are handled in integrated safety workbenches or flexible isolators reaching OEB level 4 (1-10 µg/m3).
Predefined physicochemical properties of the API can only be achieved by a carefully controlled isolation process. Besides precipitation and crystallization, lyophilization of intermediates and final API is a standard unit operation.  LaixingPharma have multiple lyophilizers in different sizes (up to 300 liters) located in clean room